Combination therapy in neuroblastoma: It's all about the mix

 

The combination of two cell division inhibitors causes malignant nervous system tumors to die off, as scientists from the "Hopp Children's Cancer...

A molecular map of childhood cancers

 

Researchers led by Professor Stefan Pfister from the “Hopp Children's Cancer Center at the NCT Heidelberg” (KiTZ) have been able to draw an extremely...

Kristian Pajtler received $100,000 award for brain cancer research

 

Kristian Pajtler, a pediatric oncologist from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ), received the 2018 CERN Scientific...

Molekular Super Enhancers: Molecular super enhancers: A new key for targeted therapy of brain cancer in children

 

Ependymoma refers to a heterogeneous group of cancers that can occur at any age and is one of the most common types of brain cancer in children. The...

€5.7 million for novel treatment approaches in pediatric brain cancer

 

Heidelberg, June 29, 2017. Children with low grade brain cancer usually suffer many years of distress. An international initiative that is coordinated...

“The chances of recovery for severely ill children are being further improved“

 

Heidelberg, January 18, 2017. To commemorate the founding of the Hopp Children’s Tumor Center at the NCT Heidelberg (KiTZ) by the Heidelberg...

The “Hopp Children's Cancer Center at NCT Heidelberg” ready to start

 

Heidelberg, 23.11.2016 Heidelberg University Hospital and the German Cancer Research Center (DKFZ) have founded the Hopp Children's Cancer Center at...